Federico Quaini
Università degli Studi di Parma
H-index: 52
Europe-Italy
Top articles of Federico Quaini
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations
Clinical & Experimental Metastasis
2024/2/16
Federico Quaini
H-Index: 33
Matteo Brunelli
H-Index: 16
Pasquale Rescigno
H-Index: 22
Alessio Signori
H-Index: 30
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders
International Journal of Molecular Sciences
2024/1/7
Luca Pagliaro
H-Index: 2
Federico Quaini
H-Index: 33
227P Sexual dimorphism in immune profile of early and advanced NSCLC
ESMO Open
2024/3/1
Bioengineering of biomimetic microenvironments for cardiac tissue engineering
Frontiers in Bioengineering and Biotechnology
2023/12/8
Federico Quaini
H-Index: 33
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC
Immuno-Oncology and Technology
2023/12/1
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients
Annals of Oncology
2023/10/1
9P Identification of a μCT-based radiomic signature of CD8+ tumour infiltrating lymphocytes in an orthotopic murine model
Annals of Oncology
2023/10/1
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes
BMJ Open Respiratory Research
2023/9/1
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors
Cancer Immunology, Immunotherapy
2023/7
Elda Favari
H-Index: 22
Alessandra Rossi
H-Index: 18
Alessio Cortellini
H-Index: 17
Luca Cantini
H-Index: 6
Federico Quaini
H-Index: 33
PO-2243 Development of a µCT radiomic platform to identify radio-immune signatures in murine tumor models
Radiotherapy and Oncology
2023/5/1
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study …
Exploration of Targeted Anti-tumor Therapy
2023
Federico Quaini
H-Index: 33
Matteo Brunelli
H-Index: 16
Integrating red blood cell features and hemoglobin levels in metastatic renal cell carcinoma patients treated with pazopanib or cabozantinib: an easily exploitable prognostic score
FRONTIERS IN BIOSCIENCE
2023
Chiara Tommasi
H-Index: 7
Giandomenico Roviello
H-Index: 22
Pasquale Rescigno
H-Index: 22
Federico Quaini
H-Index: 33
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC
Journal of Thoracic Oncology
2023
Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review
2023/1/1
Federico Quaini
H-Index: 33
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
Immuno-Oncology and Technology
2022/12/1
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML
Blood
2022/11/15
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro
Vascular pharmacology
2022/10/1
Federico Quaini
H-Index: 33
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC
Annals of Oncology
2022/9/1
P1. 15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer
Journal of Thoracic Oncology
2022/9/1
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma
Cancers
2022/7/1
Co-Authors
